Possible Mechanisms and Mediators of Gastritis Associated with Helicobacter pylori Infection

References

• Warren J R, Marshall B J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 2: 1273–1275
   Google Scholar
• Dooley C P, Fitzgibbons P L, Cohen H. Prevalence of Campylobacter pylori infection and histological gastritis in asymptomatic persons—correlation with gastric and duodenal inflammation. N Engl J Med 1989; 321: 1562–1566
   PubMed Web of Science ®Google Scholar
• Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–199
   PubMed Web of Science ®Google Scholar
• Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–1235
   PubMed Web of Science ®Google Scholar
• Blaser M J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626–633
   PubMed Web of Science ®Google Scholar
• Goodwin C S, Armstrong J A, Marshall B J. Campylobacter pyloridis gastritis and peptic ulceration. J Clin Pathol 1986; 39: 353–365
   PubMed Web of Science ®Google Scholar
• Hessey S J, Spencer J, Wyatt J I. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990; 31: 134–138
   PubMed Web of Science ®Google Scholar
• Chen X G, Correa P, Offerhaus J. Ultra-structure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol 1986; 86: 575–582
   PubMed Web of Science ®Google Scholar
• Nash S, Stafford J, Madara J L. Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1987; 80: 1104–1113
   PubMed Web of Science ®Google Scholar
• Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–625
   PubMed Web of Science ®Google Scholar
• Drumm B, O'Brien A, Cutz E, Sherman P. Campylobacter pyloridis-associated primary gastritis in children. Pediatrics 1987; 80: 192–195
   PubMed Web of Science ®Google Scholar
• Ingelhart I W, Edlow D W, Mills L, Morrison S A, Hochberg M C. The presence of Campylobacter pylori in nonsteroidal antiinflammatory drug associated gastritis. J Rheumatol 1989; 16: 599–603
   PubMed Web of Science ®Google Scholar
• Hazell S L, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658–663
   PubMed Web of Science ®Google Scholar
• Slomiany B L, Bilski J, Sarosiek J. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987; 144: 307–314
   PubMed Web of Science ®Google Scholar
• Sidebotham R L, Baron J H. Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet 1990; 335: 193–195
   PubMed Web of Science ®Google Scholar
• Baxter A, Campbell C J, Cox D M, Grinham C J, Pendlebury J E. Proteolytic activities of human Campylobacter pylori and ferret gastric Campylobacter-like organisms. Biochem Biophys Res Commun 1989; 163: 1–7
   PubMed Web of Science ®Google Scholar
• Wallace J L. Gastric resistance to acid: is the ‘mucus-bicarbonate barrier’ functionally redundant?. Am J Physiol 1989; 256: G31–G38
   Google Scholar
• Smoot D T, Mobley H LT, Chippendale G R, Lewison J F, Resau J H. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990; 58: 1992–1994
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios G M, Torres J, Torres N I, Escamilla E, Ruiz-Palacios B R, Tamayo J. Cholera-like enterotoxin produced by Campylobacter jejuni. Lancet 1983; 2: 250–253
   PubMed Web of Science ®Google Scholar
• Von Ritter C, Sekizuka E, Grisham M B, Granger D N. The chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine increases permeability in the distal ileum of the rat. Gastroenterology 1988; 95: 651–656
   PubMed Web of Science ®Google Scholar
• Von Ritter C, Be R, Granger D N. Neutrophilic proteases: mediators of formyl-methionyl-leucyl-phenylalanine-induced ileitis in rats. Gastroenterology 1989; 97: 605–609
   PubMed Web of Science ®Google Scholar
• Craig P M, Karnes W E, Territo M C, Walsh J H. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gastroenterology 1990; 98: A33
   PubMedGoogle Scholar
• Wallace J L. Lipid mediators of inflammation in gastric ulcer. Am J Physiol 1990; 258: G1–G11
   Google Scholar
• Denizot Y, Sobhani I, Rambaud J C, Lewin M, Thomas Y, Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut 1990; 31: 1242–1245
   PubMed Web of Science ®Google Scholar
• Denizot Y, Dassa E, Benveniste J, Thomas Y. Paf-acether production by Escherichia coli. Biochem Biophys Res Commun 1989; 161: 939–943
   PubMed Web of Science ®Google Scholar
• Denizot Y, Raibaud P. Ducluzeau R, Ladire M, Thomas Y, Benveniste J. Modulation of gut wall paf-acether and precursors by intestinal microflora. Res Immunol 1990; 141: 235–240
   PubMedGoogle Scholar
• Braquet P, Touqui L, Shen T Y, Vargaftig B B. Perspectives in platelet-activating factor research. Pharmacol Rev 1987; 39: 97–145
   PubMed Web of Science ®Google Scholar
• Dulioust A, Vivier E, Salem P, Benveniste J, Thomas Y. Immunoregulatory functions of Pafacether. I. Effect of Paf-acether on CD4+ cell proliferation. J Immunol 1988; 140: 240–245
   PubMed Web of Science ®Google Scholar
• Rosam A C, Wallace J L, Whittle B JR. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature, 319: 54–56
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins 1986; 31: 989–998
   PubMed Web of Science ®Google Scholar
• Wallace J L, Hogaboam C M, McKnight G W. Platelet-activating factor (PAF) mediates gastric damage induced by hemorrhagic shock. Am J Physiol 1990; 259: G140–G146
   PubMedGoogle Scholar
• Wallace J L, Steel G, Whittle B JR, Lagente V, Vargaftig B B. Evidence for platelet-activating factor (Paf) as a mediator of endotoxin-induced gastrointestinal damage in the rat: effects of three Paf antagonists. Gastroenterology 1987; 93: 765–773
   PubMed Web of Science ®Google Scholar
• Hanglow A C, Bienenstock J, Perdue M H. Effects of platelet-activating factor on ion transport in isolated rat jejunum. Am J Physiol 1989; 257: G845–G850
   Google Scholar
• Ford-Hutchinson A W. Leukotriene B4 in inflammation. Crit Rev Immunol 1990; 10: 1–22
   PubMed Web of Science ®Google Scholar
• Chan C C, McKee K, Tagari P, Chee P, Ford-Hutchinson A W. Eosinophil-eicosanoid interactions: inhibition of eosinophil chemotaxis in vivo by a LTD4-receptor antagonist. Eur J Pharmacol 1990; 191: 273–280
   PubMed Web of Science ®Google Scholar
• Wallace J L, McKnight W K, Keenan C M, Byles N IA, MacNaughton W K. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 1990; 98: 1178–1186
   PubMed Web of Science ®Google Scholar
• Krakowka S, Morgan D, Kraft W, Leunk R. Establishment of gastric Campylobacter pylori infection in neonatal gnotobiotic piglet. Infect Immun 1987; 55: 2789–2796
   PubMed Web of Science ®Google Scholar
• Lee A, Fox J G, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990; 99: 1315–1323
   PubMed Web of Science ®Google Scholar
• Smoot D T, Rosenthal L E, Mobley H LT, Iseri O, Zhu S, Resau J H. Development of a human stomach explant organ culture system to study the pathogenesis of Helicobacter pylori. Digestion 1990; 46: 46–54
   PubMed Web of Science ®Google Scholar
• Rosenberg K, Hubinette R, Nygard G, Berglindh T, Rolfsen W. Studies of Helicobacter pylori in a gastric mucosa in vitro animal model. Scand J Gastroenterol 1991; 26: 43–48
   PubMed Web of Science ®Google Scholar